The Patent Finder

Celldex Therapeutics, Inc.

Also on record
Records under this name other than the patents Celldex Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 25 patents it holds.

Back to Celldex Therapeutics, Inc.

PatentTitleStatus Expires Confidence
US 10,668,152Use of ANTI-PD-1 Antibody in Combination with ANTI-CD27 Antibody in Cancer Treatment
Formerly held
In force
 · Low confidence
In forceLow confidence
US 11,180,566Antibodies that bind human CD27 and uses thereof
Lapsed on the fee record
Ended Nov 23, 2025 · From the USPTO record
Lapsed on the fee recordEnded Nov 23, 2025From the USPTO record
US 9,649,356Method of improving transplant function using soluble complement receptor type I (sCR1)
Lapsed on the fee record
Ended May 16, 2025 · From the USPTO record
Lapsed on the fee recordEnded May 16, 2025From the USPTO record
US 9,624,300Antibodies that bind human dendritic and epithelial cell 205 (DEC-205)
Lapsed on the fee record
Ended Apr 18, 2025 · From the USPTO record
Lapsed on the fee recordEnded Apr 18, 2025From the USPTO record
US 10,745,490Anti-Erbb Antibodies and Methods of Use Thereof
Formerly held
Lapsed on the fee record
Ended Aug 18, 2024 · High confidence
Lapsed on the fee recordEnded Aug 18, 2024High confidence
US 8,236,318Antibodies that bind human dendritic and epithelial cell 205 (DEC-205)
Lapsed on the fee record
Ended Aug 7, 2024 · From the USPTO record
Lapsed on the fee recordEnded Aug 7, 2024From the USPTO record
US 8,846,873Antibodies Directed to Gpnmb and Uses Thereof
Lapsed on the fee record
Ended Sep 30, 2022 · Medium confidence
Lapsed on the fee recordEnded Sep 30, 2022Medium confidence
US 8,664,176Treatment for age-related macular degeneration and other diseases of the eye
Lapsed on the fee record
Ended Mar 4, 2022 · From the USPTO record
Lapsed on the fee recordEnded Mar 4, 2022From the USPTO record
US 8,586,720Antibodies that bind human dendritic and epithelial cell 205 (DEC-205)
Lapsed on the fee record
Ended Nov 19, 2021 · From the USPTO record
Lapsed on the fee recordEnded Nov 19, 2021From the USPTO record
US 7,563,876Human monoclonal antibodies to dendritic cells
Formerly held
Lapsed on the fee record
Ended Jul 21, 2021 · From the USPTO record
Lapsed on the fee recordEnded Jul 21, 2021From the USPTO record
10 of 77 patents shown.
Pro members see all 77.
Pro members: see all 77 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited